Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Metropolis Healthcare Ltd Stock Analysis

Mid Cap
Evaluated by 558 users | BSE: 542650 | NSE: METROPOLIS |
Hospital & Healthcare Services

Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The...

1. Right Stock
Very Good
2. Right Price
3. Right Time

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Metropolis Healthcare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 000015.71%23.37%30.97%27.37%28.56%28.29%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0000455524545647761856
Y-o-Y Gr. Rt.-NANANANA15.2%4%18.8%17.6%12.5%
Adjusted EPS (Rs.) 000061.7883.31102.03108.5324.1225.15
Y-o-Y Gr. Rt.-NANANANA34.9%22.5%6.4%-77.8%4.3%
Book Value per Share (Rs.) 0000366.26277.67338.57432.8282.89102.99
Adjusted Net Profit 000060.979.597.4104121127
Net Op. Cash Flow (Rs. Cr.) 000069.788.210210490.2215
Debt to Cash Flow from Ops 00000.20.080.010.010.20
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Metropolis Healthcare Ltd. should be analysed on a Consolidated basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NA13.5%16.3%12.5%
Adjusted EPS NA-16.5%-37.3%4.3%
Book Value per Share 0-22.4-32.824.3
Share Price - - - 89.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 000016.8725.3933.1128.0729.0527.04
Operating Profit Margin (%) 000025.8526.2228.3827.9626.9927.76
Net Profit Margin (%) 000014.9116.7618.917.1816.5414.96
Debt to Equity 00000.040.03000.040
Working Capital Days 000008282160218187
Cash Conversion Cycle 000002218233318
Corporate Governance What do we look at?
Corporate Governance
Board Credentials
Promoter's holding
Transparency
Integrity
Entity Percentage Holding
Promoters 50.38%
Institutions 42.97%
Non-Institutions 6.65%
Pledged *0.000.0045.2945.2933.8333.8337.855.445.443.30
* Pledged shares as % of Promoter's holding (%)

MoneyWorks4Me analysed the past 10-year performance of Metropolis Healthcare Ltd and arrived at the following conclusion:

Past 10 year's financial track record indicates that Metropolis Healthcare Ltd is a good quality company. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company.

Data is not available for this company

Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.

With its widespread operational network,

Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.

With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.

Business area of the company

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Services

  • Pathology Testing Services
  • Corporate Wellness
  • Lab in Hospitals
  • Clinical Research Services

Awards

FY2018-19

  • The Global Reference Laboratory of Metropolis holds accreditation from the College of American Pathologists (CAP) since 2005 which is the gold standard in accreditations in industry, globally.
  • Metropolis Healthcare was awarded Iconic Pathology Lab Award by Mid-Day Health & Wellness Awards in September 2018
  • Metropolis received the ‘Best Diagnostic Laboratory’ in India award at the Women’s Health Conference 2019
  • Metropolis was awarded special jury mention for “Service Excellence (Diagnostic Centre)” by FICCI at the Healthcare Excellence Awards 2018
  • Metropolis Healthcare won the Best Temperature Controlled Project of the year at the Cold Chain Summit Awards held in Mumbai, 2018
  • Metropolis Healthcare honored for Excellence in Customer Service & Delivery at the Home Healthcare Summit & Awards 2018
  • Company was awarded for “Best in Health and Fitness” in the Digital Campaign Awards by LH Insights 2018.

FY2019-20

  • Accorded as the Most Admired Healthcare Company of The Year - February 2020
  • Won the award for Best It Practices at the Data Center Summit 2019 - October 2019
  • Awarded as the Best Patient Experience Team Of The Year Award at PEXA Awards 2019, in Delhi - December 2019
  • Won the Healthcare Leadership Award, at the Uttar Pradesh Healthcare Leadership Awards 2019 held at Lucknow - October 2019
  • Bagged Excellence In Logistics award at the CII SCALE Awards 2019 - Supply Chain & Logistics Excellence Awards organised by Confederation of Indian Industries - December 2019
  • Awarded the Best It Enabled Pathology Chain Award during the 4th Digital Innovation Health Summit and CIO Awards at Kolkata
  • Won a special mention as the Best Performance-Driven Digital Campaign Award at the InkSpell Drivers of Digital Awards 2019 - December 2019
  • Conferred the Best Logistics Network Optimization & Best Use Of Technology In Logistics awards announced at the 5th Asian Supply Chain Thought Leadership Summit & Awards in Mumbai - November 2019

Major Events & Milestones

  • 2002: First major acquisition by company of Sudharma.
  • 2004: The company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology, India).
  • 2005: The company received accreditation from The College of American Pathologists.
  • 2006: Investment by The Western India Trustee and Executor company in company.
  • 2006: Acquisition of Lister Laboratory and Research Centre Private Limited in Chennai.
  • 2007: Acquisition of Desai Clinical Laboratory in Surat.
  • 2008: Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore.
  • 2010: Investment by Foxcreek Investment Limited in company.
  • 2012: Acquisition of Micron Laboratories in Mumbai.
  • 2012: Incorporation of subsidiary in Mauritius.
  • 2013: Establishment of GRL in Mumbai.
  • 2014: Acquisition of subsidiary in Ghana.
  • 2015: Investment by CA Lotus Investments in company.
  • 2015: Incorporation of subsidiary in Uganda.
  • 2015: Incorporation of branch office in Zambia.
  • 2017: Acquisition of Sanjeevani Pathology Laboratory in Rajkot.
  • 2018: 2018 Public-Private partnership agreement executed with National AIDS Control Organisation, Government of India.
  • 2018: Scheme of Amalgamation 2018.
  • 2018: Incorporation of subsidiary in Tanzania.
  • 2020: Metropolis Healthcare executes pact to acquire 51% stake in Shraddha Diagnostic Centre
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback